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Background: The well-known genetic polymorphisms in ADH1B(His47Arg) and ALDH2(Glu487Lys) have dramatic
effects on the rate of metabolizing alcohol and acetaldehyde. We investigated possible involvement of these
functional polymorphisms in other common complex-trait diseases.
Methods: The genetic effects of these two polymorphisms on hepatitis, asthma, type-2 diabetes mellitus (T2DM),
and tuberculosis (TB) were examined in a Korean population.
Results: We demonstrated that the well-known functional polymorphism of a primary alcohol-metabolizing enzyme
(ALDH2 Glu487Lys) has a strong genetic association with the risk of TB. The frequency of the minor allele (ALDH2*487Lys)
was found to be much lower in TB patients (freq. = 0.099/n = 477) than among controls (freq. = 0.162/n = 796)
(P = 0.00001, OR (95% confidential interval) = 0.57 (0.45-0.74)). Our data may indicate that TB was once an endemic
disease, which exerted selection pressure for higher frequencies of ALDH2*487Lys in Asian populations. In addition, the
calculated attributable fraction (AF) indicates that 39.5% of TB patients can attribute their disease to the detrimental
effects of ALDH2Glu487Glu.
Conclusion: Our results suggest that this polymorphism is one of the genetic components of TB, at least in the Korean
population.
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The alcohol dehydrogenases (ADHs), especially ADH1B,
convert alcohol to acetaldehyde. Subsequently, the al-
dehyde dehydrogenases (ALDHs), mainly ALDH2, oxi-
date the acetaldehyde into acetate. Encoding genes for
these two representative alcohol-metabolizing enzymes
display polymorphisms (ADH1B His47Arg and ALDH2
Glu487Lys) that show different alcohol/acetaldehyde oxidiz-
ing capability among individuals [1-4]. The ADH1B*47His
allele represents a much higher activity of ADH1B with
about 40 times higher Vmax than the homozygotes for* Correspondence: hdshin@sogang.ac.kr
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reproduction in any medium, provided the orthe ADH1B*47Arg form, which enables increased alcohol
elimination from the blood after alcohol consumption
[1,5]. The ALDH2*487Lys allele encodes a catalytically in-
active subunit [1,5], which causes alcohol-related adverse
reactions [6]. These adverse reactions in subjects with
ALDH2*487Lys, as a result of excessive acetaldehyde ac-
cumulation, tend to reduce alcohol consumption, con-
sequently reducing the risk of alcoholism.
We previously demonstrated that ADH1B*47Arg and
ALDH2*487Lys were dramatically associated with the
risk of alcoholism in a Korean population [7,8]. In
addition, when combined, the two loci revealed major
genetic effects on the risk of alcoholism [9]. To investi-
gate possible involvement of these functional polymor-
phisms in other common complex-trait diseases, we
examined their genetic effects on HBV (hepatitis B virus). This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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tuberculosis (TB) in a Korean population.
Methods
Study subjects and genotyping of polymorphisms
Information about the study subjects was provided in previ-
ous studies (number of samples may differ slightly) as fol-
lows: HBV (hepatitis B virus) hepatitis [10], asthma [11],
T2DM [12], and tuberculosis (TB) [13]. Briefly, the follow-
ing subjects were included: a total of 963 subjects for the
hepatitis study (537 chronic carriers [mean age = 55.0,
range = 23-82] and 426 spontaneously recovered subjects
from hepatitis B [mean age = 55.0, range = 29-79]), 1,796
subjects for the asthma study (1,259 asthma patients
[mean age = 33.8, range = 22-65] and 537 controls [mean
age = 37.1, range = 32-56]), 1,359 subjects for the T2DM
study (745 T2DM patients [mean age = 57.1, range = 43-
72] and 614 controls [mean age = 65.5, range = 45-76]),
1,032 subjects for the alcoholism study (549 alcoholics [all
males; mean age = 46.1, range = 20–73] and 483 controls
[all male; mean age = 33.2, range = 20–77]), and 1,273
subjects for the TB study (447 TB patients [all male;
mean age = 46.7, range = 20–86] and 796 controls [all
male; mean age = 54.9, range = 40–69]). Inclusion criteria
were described in previous studies [11-13].
Statistics
χ2 tests were used to determine if the individual variants
were in Hardy-Weinberg equilibrium (HWE). Logistic
regression analyses, controlling for age and gender as co-
variates, were used to calculate odds ratios and the P-values
for case–control analysis. All statistical analyses were per-
formed using SAS 9.1 (SAS Institute, Inc., Cary, NC, USA).
The attributable fraction (AF) was calculated by the for-
mula AF = f(R ⋅ − 1)/(1 + f(R ⋅ − 1)), where f is the frequency
of the risk factor in the population, and R is the measure of
the odds ratio [14].
Results
The genotype distributions of ADH1B His47Arg and
ALDH2Glu487Lys were not found to deviate from HWE
(P > 0.05) except in alcoholic patients (ADH1B His47Arg).
(For comparison, the results of our previous study of two
polymorphisms and their association with alcoholism [9]
have been added to Table 1). Logistic regression analysis
did not show any significant association with the clearance
of hepatitis B virus or with the risks of asthma, T2DM, or
TB (Table 1). However, a strong genetic association of
ALDH2Glu487Lys with the risk of TB was observed. The
frequency of the minor allele was much lower in TB pa-
tients (freq. = 0.099/n = 477) than in controls (freq. =
0.162/n = 796) (P = 0.00001, OR (95% confidential inter-
val) = 0.57 (0.45-0.74), Table 1). The overall allele frequen-
cies of ALDH2*487Lys ranged from 0.161–0.181, except inalcoholic patients (freq. = 0.017) and TB patients (freq. =
0.099), in the Korean population.
Further referent and alternative (co-dominant, domin-
ant, and recessive model) analysis of ALDH2Glu487Lys
revealed that its genetic mode for the risk of TB is ap-
parently protective and dominant, when comparing the
magnitude (OR) of associations of heterozygotes and
homozygotes for ALDH2*487Lys, although no signifi-
cance was detected for homozygotes due to a low num-
ber of samples (Table 2). Only 18.1% of TB patients had
the protective allele (ALDH2*487Lys), compared with 29.7%
of controls (dominant mode; OR = 0.52 [95% confidential
interval (CI), 0.39-0.69], P = 000004) (Table 2).
The AF was calculated by frequency of risk genotype
(ALDH2*Glu/Glu, 70.2%) and its odds ratio (1.93) based
on controls (Table 2). The AF indicates that 39.5% of TB
patients can attribute their disease to the detrimental
effects of ALDH2*Glu/Glu in the Korean population.
Discussion
Tuberculosis is one of the oldest diseases known to
mankind; it is also a leading cause of death among
adults, and it kills almost 500 children each day world-
wide. More than 90% of TB-related deaths occur in de-
veloping countries. The incidence of TB was declared a
global emergency by the World Health Organization
(WHO) in 1993, with around 8–10 million new cases of
the disease each year and 2–3 million deaths worldwide
(WHO Report, 2005). A worldwide health problem that
reached a peak in the nineteenth century, it was thought
to have been brought under control by the l960s due to
active public health measures and the use of modern
drug therapies. However, this complacency led to reduced
funding for the diagnosis and treatment of TB at the same
time that the bacterium was developing resistance to the
drugs used to treat it. The problem has been compounded
since the 1980s by the emergence of a new population of
vulnerable individuals—those infected with HIV.
Approximately one third of the world’s population is la-
tently infected with Mycobacterium tuberculosis, which
causes TB. However, only 10% of those infected are esti-
mated to progress to active (clinical) TB. A large body of
epidemiological data links polymorphisms in various host
genes to increased susceptibility to TB [15-17]. These host
genetic factors are among the important determinants of
susceptibility to the disease [18]. The doubly high risk of
disease in identical twins compared with non-identical
twins [19] strongly indicates a host genetic component.
There have been many studies on TB susceptibility based
on candidate-gene approaches. Recently, several genome-
wide association studies (GWASs) identified susceptibility
loci for tuberculosis on chromosome 18q11.2 [20], chromo-
some 11p13 [21], chromosome 20q12 [22], and eight genes
involved in immune signaling [23].
Table 1 Analysis of genetic effect of ADH1B His47Arg and ALDH2 Glu487Lys on the risk of various diseases in a Korean
population (n = 6,423)
Loci Disease Group Genotype Total N MAFa HWEb OR (95% CI)c Pc
His/His His/Arg Arg/Arg
ADH1B His47Arg Hepatitis CCd 317(59.0%) 196(36.5%) 24(4.5%) 537 0.227 0.361 0.95 (0.76-1.18) 0.64
SRd 243(57.1%) 165(38.7%) 18(4.2%) 426 0.236 0.125
Asthma Case 708(56.2%) 464(36.9%) 87(6.9%) 1259 0.253 0.358 0.99 (0.84-1.17) 0.91
Control 295(54.8%) 210(39.2%) 32(6.0%) 537 0.256 0.503
T2DM Case 449(60.3%) 251(33.7%) 45(6.0%) 745 0.229 0.214 0.91 (0.76-1.08) 0.28
Control 349(56.8%) 227(37.0%) 38(6.2%) 614 0.247 0.893
Alcoholisme Case 217(39.5%) 145(26.4%) 187(34.1%) 549 0.473 3.172 × 10−28 2.38 (2.00-2.82) 1.28E-22
Control 298(61.7%) 155(32.1%) 30(6.2%) 483 0.223 0.893
TB Case 273(57.2%) 169(35.4%) 35(7.4%) 477 0.251 0.217 1.01 (0.84-1.22) 0.89
Control 450(56.5%) 297(37.3%) 49(6.2%) 796 0.248 0.999
ALDH2Glu487Lys Hepatitis CC 372(69.3%) 157(29.2%) 8(1.5%) 537 0.161 0.058 1.02 ( 0.80-1.31) 0.88
SR 305(71.6%) 107(25.1%) 14(3.3%) 426 0.158 0.230
Asthma Case 860(68.3%) 358(28.4%) 41(3.3%) 1259 0.175 0.617 1.17 (0.96-1.41) 0.12
Control 385(71.7%) 139(25.9%) 13(2.4%) 537 0.154 0.914
T2DM Case 498(66.8%) 224(30.1%) 23(3.1%) 745 0.181 0.718 1.05 (0.87-1.28) 0.60
Control 426(69.4%) 163(26.5%) 25(4.1%) 614 0.173 0.066
Alcoholisme Case 530(96.5%) 19(3.5%) 0(0.0%) 549 0.017 0.680 0.10 (0.06-0.16) 3.88E-20
Control 346(73.6%) 122(25.3%) 15(3.1%) 483 0.265 0.297
TB Case 391(82%) 78(16.4%) 8(1.7%) 477 0.099 0.082 0.57 (0.45-0.74) 0.00001
Control 559(70.2%) 216(27.1%) 21(2.6%) 796 0.162 0.980
aMAF: minor allele frequency.
bP-value of genotype distribution deviation from Hardy-Weinberg equilibrium.
cLogistic regression models (co-dominant model) were used for calculating odds ratios (95% confidential interval) and corresponding P-values.
dCC: chronic carrier/SR: spontaneously recovered.
eKim et al. (2008) [9].
Bold faces indicate P<0.05.
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polymorphism in a primary alcohol-metabolizing enzyme
(ALDH2Glu487Lys) is a genetic component underlying
susceptibility to TB in a Korean population. The protect-
ive effect of ALDH2*487Lys on TB could be explained
through the well-known function of this variant in alcohol
metabolism. Although ADH1B*47 is involved in alcohol
elimination from the blood after consumption (alcohol to
acetaldehyde), it is not directly involved in alcohol-related
adverse reactions. However, the ALDH2*487Lys allele en-
codes an inactive converting enzyme (acetaldehyde into
acetate), resulting in excessive accumulated acetaldehyde,Table 2 Analysis of genetic effect of ALDH2 Glu487Lys on risk
Genotype TB Control Referent analysisa Co-d
OR (95% CI) P OR (95
Glu/Glu 391(82%) 559(70.2%) 1 -
Glu/Lys 78(16.4%) 216(27.1%) 0.52 (0.39-0.69) 0.000008 0.57 (0.4
Lys/Lys 8(1.7%) 21(2.6%) 0.55 (0.24-1.24) 0.15
aOdds ratio and P-value of individual genotype as compared to common genotype
Bold faces indicate P<0.05.which causes alcohol-related adverse reactions includ-
ing flushing, palpitation, nausea, headache, drowsiness,
breathlessness, and general discomfort [1,5,6]. These
adverse reactions likely lead to reduced alcohol abuse,
which in turn helps to maintain better general health
and reduces the risk of TB, along with other confound-
ing factors.
Interestingly, the genotype distribution of ALDH2 dif-
fers greatly between Asian, especially East Asian, and
other major populations. In fact, ALDH2*487Lys has
only been detected in East Asian populations [24]. The
hypothesis of selection pressure for lower ALDH2of TB (n = 1,273)
ominant model Dominant model Recessive model
% CI) P OR (95% CI) P OR (95% CI) P
5-0.74) 0.00001 0.52 (0.39-0.69) 0.000004 0.63 (0.28-1.43) 0.27
in referent analysis.
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disease(s) in areas with high frequency of ALDH2*487Lys,
seems like one of the most plausible explanations. It is not
easy to prove, historically, given the time period during
which it operated. However, based on the higher preva-
lence of TB and higher frequencies of ALDH2*487Lys in
East Asian populations, a likely hypothesis is that TB is or
was an endemic disease in Korean and possibly Japanese
and Chinese populations. This could have exerted selec-
tion pressure that accounts for the higher frequencies of
ALDH2*487Lys in Asian populations.
Conclusions
In this paper, we demonstrated that the well-known func-
tional polymorphism of a primary alcohol-metabolizing
enzyme (ALDH2 Glu487Lys) has a genetic association
with the risk of TB. We also offer evidence that TB may
have been an endemic disease in Asian populations, which
exerted selection pressure resulting in higher frequencies
of ALDH2*487Lys. In addition, the AF indicates that alco-
holism in 39.5% of TB patients in the Korean population
can be attributed to the detrimental effect of ALDH2*487-
Glu, which suggests that this polymorphism is one of the
genetic components of TB, at least among Koreans.
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